ANKS6
protein-codingankyrin repeat and sterile alpha motif domain containing 6, the group of Ankyrin repeat domain containing|Sterile alpha motif domain containing
Gene summary
This gene encodes a protein containing multiple ankyrin repeats and a SAM domain. It is thought that this protein may localize to the proximal region of the primary cilium, and may play a role in renal and cardiovascular development. Mutations in this gene have been shown to cause a form of nephronophthisis (NPHP16), a chronic tubulo-interstitial nephritis. [provided by RefSeq, Jul 2015]
- SAMD6
- ANKRD14
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~65.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014158
Submitter: ClinGen
Biallelic ANKS6 pathogenic variants were first reported in relation to autosomal recessive cystic kidney disease in 2013 (Hoff et al., PMID: 23793029) and have been associated with Nephronophthisis 16 (OMIM #615382). ANKS6 is a critical component of the ciliary complex required for kidney and cardiovascular development and affected patients develop progressive kidney dysfunction that may or may not be accompanied by extrarenal manifestations, including hypertrophic obstructive cardiomyopathy, aortic stenosis, pulmonary stenosis, patent ductus arteriosus, situs inversus, and periportal liver fibrosis. At least 8 variants (3 frameshift, 3 splice, 2 missense) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 7 probands in 5 publications (PMIDs: 23793029; 31678577; 31635528, 24610927, 26489029). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be biallelic loss of function. This gene-disease association is supported by animal models, expression studies, and protein interactions (PMIDs: 26039630, 25599650, 23793029). In summary, ANKS6 is definitively associated with autosomal recessive nephronophthisis (NPHP-ANKS6). This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cystic and Ciliopathy Disorders GCEP on 08/25/21 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0009728
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011190
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014158
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014158
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Gastrointestinal; Renal
Intervention: Cardiovascular
Rationale: Individuals have been described with congenital heart anomalies, and awareness may enable early diagnosis and management
Comments: Renal transplant has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ANKS6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_173551.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 126 | 1 | 132 | ||
| missense | 3 | 310 | 27 | 3 | 343 | |
| nonsense | 5 | 8 | 3 | 16 | ||
| start loss | 0 | |||||
| frameshift | 12 | 9 | 2 | 23 | ||
| splice donor/acceptor (+/-2bp) | 2 | 4 | 6 | 12 | ||
| Total | 19 | 24 | 326 | 153 | 4 | 526 |
Highest pathogenic variant AF is 0.00003965918
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_775822.3 | 15 | MANE Select | |
| Ensembl | ENSP00000297837.6 | 15 | MANE Select | |
| Ensembl | ENSP00000364159.2 | 14 | Standard | |
| Ensembl | ENSP00000364159.2 | 14 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Molecular Function
- protein binding
Cellular Component
- cytoplasm
- cilium
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000353234
- Coding exons
- 15
- Length
- 65637
- Individuals with no LoFs
- 124731
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 66
- Defined
- 124797
- p
- 0.000264
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.0756 | 463 | 458 | 1.01 | 0.0000279 | 5561 |
| Missense (PolyPhen) | 130 | 147.33 | 0.88238 | 1742 | ||
| Synonymous | 0.121 | 199 | 201 | 0.989 | 0.0000139 | 1865 |
| Loss of Function | 2.89 | 14 | 31.5 | 0.444 | 0.00000168 | 380 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000065 | 0.000065 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00028 | 0.00027 | rare |
| South Asian | 0.00064 | 0.00059 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Required for renal function. {ECO:0000269|PubMed:23793029}.;
- Disease
- DISEASE: Nephronophthisis 16 (NPHP16) [MIM:615382]: A form of nephronophthisis, a chronic tubulo-interstitial nephritis that progresses to end-stage renal failure. Some patients have cystic kidneys of normal size and no extrarenal manifestations, whereas others have enlarged renal size and severe extrarenal defects, including hypertrophic obstructive cardiomyopathy, aortic stenosis, pulmonary stenosis, patent ductus arteriosus, situs inversus, and periportal liver fibrosis. {ECO:0000269|PubMed:23793029}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- LoFtool
- 0.678
- RVIS EVS
- -0.35
- RVIS percentile EVS
- 29.59
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.339
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |